全文获取类型
收费全文 | 540篇 |
免费 | 22篇 |
国内免费 | 16篇 |
专业分类
儿科学 | 32篇 |
妇产科学 | 2篇 |
基础医学 | 60篇 |
口腔科学 | 37篇 |
临床医学 | 73篇 |
内科学 | 104篇 |
皮肤病学 | 3篇 |
神经病学 | 12篇 |
特种医学 | 114篇 |
外科学 | 56篇 |
综合类 | 32篇 |
预防医学 | 7篇 |
眼科学 | 1篇 |
药学 | 35篇 |
中国医学 | 1篇 |
肿瘤学 | 9篇 |
出版年
2021年 | 2篇 |
2020年 | 3篇 |
2019年 | 4篇 |
2018年 | 6篇 |
2017年 | 3篇 |
2016年 | 6篇 |
2015年 | 14篇 |
2014年 | 18篇 |
2013年 | 21篇 |
2012年 | 28篇 |
2011年 | 19篇 |
2010年 | 26篇 |
2009年 | 19篇 |
2008年 | 16篇 |
2007年 | 18篇 |
2006年 | 12篇 |
2005年 | 8篇 |
2004年 | 2篇 |
2003年 | 10篇 |
2002年 | 12篇 |
2001年 | 10篇 |
2000年 | 16篇 |
1999年 | 15篇 |
1998年 | 25篇 |
1997年 | 28篇 |
1996年 | 26篇 |
1995年 | 18篇 |
1994年 | 19篇 |
1993年 | 16篇 |
1992年 | 4篇 |
1991年 | 5篇 |
1990年 | 6篇 |
1989年 | 23篇 |
1988年 | 20篇 |
1987年 | 14篇 |
1986年 | 16篇 |
1985年 | 10篇 |
1984年 | 5篇 |
1983年 | 8篇 |
1982年 | 3篇 |
1981年 | 7篇 |
1980年 | 10篇 |
1979年 | 6篇 |
1978年 | 4篇 |
1977年 | 2篇 |
1976年 | 4篇 |
1975年 | 5篇 |
1932年 | 1篇 |
1925年 | 1篇 |
1924年 | 1篇 |
排序方式: 共有578条查询结果,搜索用时 0 毫秒
111.
Yavuz K Geyik S Hoppe H Kolbeck KJ Kaufman JA 《Journal of vascular and interventional radiology : JVIR》2008,19(4):504-508
PURPOSE: To determine the incidence of venous thromboembolism (VTE) after removal of retrievable inferior vena cava (IVC) filters. MATERIALS AND METHODS: Retrospective study was conducted of 67 patients who underwent 72 consecutive filter retrievals at a single institution. Data collected included VTE status at the time of filter placement, anticoagulant medications at the time of filter retrieval and afterward, new or recurrent VTE after filter removal, and insertion of subsequent filters. Patient questionnaires were completed in 50 cases, chart review in all patients. RESULTS: At the time of filter placement, 30 patients had documented VTE, 19 had a history of treated VTE, and 23 were at risk for but had neither previous nor present VTE. Mean duration of follow-up after filter removal was 20.6 months +/- 10.9. A total of 52 patients (57 filters) received anticoagulation and/or antiplatelet medications after filter removal. There were two documented episodes of recurrent deep vein thrombosis (2.8% of filters removed), both in patients who had VTE at the time of filter placement and underwent therapeutic anticoagulation at the time of filter removal. One of these patients (1.4% of filters removed) also experienced pulmonary embolism. Of the 23 patients without VTE when the filter was placed, none developed VTE after filter removal. Four patients (5.5% of filters removed) required subsequent permanent filters, three for complications of anticoagulation, one for failure of anticoagulation. CONCLUSIONS: VTE was rare after removal of IVC filters, but was most likely to occur in patients who had VTE at the time of filter placement. 相似文献
112.
113.
Statin therapy may prevent an excessive inflammatory response after cardiopulmonary bypass for cardiac surgery. In a recent
issue of Critical Care, Morgan and colleagues present data from a well-conducted systematic review and meta-analysis of randomised controlled trials
using inflammatory markers as primary outcome measure. They find that pre-operative statin therapy, compared with placebo,
may reduce various post-operative markers of systemic inflammation (IL-6, IL-8, C-reactive protein, tumour necrosis factor-alpha).
Their ability to make definitive conclusions is limited, however, by the suboptimal methodological quality of the primary
studies. Their review suggests that ICU researchers should focus on developing valid surrogate markers and use these to accurately
describe the mechanisms and effectiveness of novel therapies before proceeding to large pragmatic trials using mortality as
primary outcome. 相似文献
114.
Background
Selective serotonin reuptake inhibitors (SSRIs), a popular class of antidepressants, may increase breast cancer risk by stimulating the secretion of prolactin, a potential tumour promoter. We evaluated the effects of duration of SSRI use, cumulative dose, and latency on the risk of breast cancer by conducting a population-based case-control study utilizing Saskatchewan health databases. 相似文献115.
116.
Hepatic arterial chemotherapy: role of angiography 总被引:2,自引:0,他引:2
Hepatic arterial infusion chemotherapy increases the hepatic concentration of chemotherapeutic agents without increasing systemic toxicity. Both percutaneous (most commonly left transbrachial) and surgical approaches are currently used for infusion catheter placement. Surgical catheter and pump placement has proved to be a reliable means of delivering drugs to the liver and has been commonly used for hepatic arterial chemotherapy for metastatic colorectal carcinoma. Meticulous angiographic evaluation of the hepatic vascular anatomy, its variations, and hemodynamics is necessary for correct catheter placement to achieve total liver perfusion without significant extrahepatic perfusion. Satisfactory hepatic perfusion should be documented before drug infusion. Hepatic arterial radionuclide flow imaging with technetium-99m-labeled macroaggregated serum albumin remains the most reliable means of assessing hepatic perfusion following catheter placement. Transcatheter techniques have been used to facilitate catheter placement, to prevent gastrointestinal drug toxicity, and to correct unsatisfactory perfusion following surgical catheter placement. 相似文献
117.
118.
119.
The absence of a vertebral pedicle, regardless of location, always merits careful consideration. There are a variety of disease states in addition to intrinsic mechanisms which may influence the development of the spine and hence potentiate pedicular absence. Each of these diseases or processes must be considered when confronted by a missing pedicle. This paper will identify and briefly discuss the most common conditions resulting in pedicular absence. 相似文献
120.
JE Kist-van Holthe tot Echten J Nauta WC Hop MC de Jong WC Reitsma-Bierens SL Ploos van Amstel KJ van Acker CM Noordzij ED Wolff 《Archives of disease in childhood》1993,68(3):371-375
The aim of the study was to investigate the effect of a protein restricted diet on renal function and growth of children with chronic renal failure. In a multicentre prospective study 56 children (aged 2-18 years) with chronic renal failure were randomly assigned to the protein restricted (0.8-1.1 g/kg/day) or the control group. All children were followed up by the same paediatrician and dietitian. After a follow up period of three years there was no significant difference in glomerular filtration rate between children on a protein restricted diet and children of the control group. There was no significant difference in weight with respect to height and height SD score between the protein restricted and the control group. Compliance with the protein restricted diet, as indicated by the prospective diet diaries and the serum urea:creatinine ratio, was good. This study shows that children with chronic renal failure do not benefit from a protein restricted diet. 相似文献